login
login

Europe Daily Bulletin No. 12415

31 January 2020
Contents Publication in full By article 22 / 25
COURT OF JUSTICE OF THE EU / Competition
Court sets criteria for assessing agreements between pharmaceutical manufacturers and generic companies
Brussels, 30/01/2020 (Agence Europe)

The Court of Justice of the European Union has clarified the criteria for establishing that an agreement to settle a dispute between a pharmaceutical patent holder and a generic company is contrary to EU competition law in a judgment delivered on Thursday 30 January (Case C-3071/8).

Holder of a patent on the active pharmaceutical ingredient of an antidepressant drug and secondary patents protecting certain processes for the manufacture of that ingredient, the GlaxoSmithKline group (GSK)...

Contents

SECTORAL POLICIES
EUROPEAN PARLIAMENT PLENARY
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
EXTERNAL ACTION
COURT OF JUSTICE OF THE EU
COUNCIL OF EUROPE
NEWS BRIEFS